Stay updated with breaking news from Cov Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from CureVac, CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2022 and Provides Business Update
Delivering on broad second-generation vaccine development program with expansion into modified mRNA technology in collaboration with GSKPhase 1 studies in influenza and COVID-19 on track to deliver clinical
Issuer: CureVac / Key word(s): Quarter Results18.08.2022 / 13:05 The issuer is solely responsible for the content of this announcement.CureVac Announces Financial Results for the Second Quarter and First Half of 2022 and Provides Business Update Delivering on broad 2022 second-generation vaccine development program...
Delivering on broad 2022 second-generation vaccine development program with expansion into modified mRNA technology in collaboration with GSK; new candidates in COVID-19 and influenza enter clinical studiesPhase
18.08.2022 - Issuer: CureVac / Key word(s): Quarter Results CureVac Announces Financial Results for the Second Quarter and First Half of 2022 and Provides Business Update 18.08.2022 / 13:05 The issuer is solely responsible for the content of this ...